Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Beginning balance at Dec. 31, 2022	$ 387	$ 601,105	$ 387	$ (331,096)	$ 270,783
Beginning balance (in shares) at Dec. 31, 2022	29,873,893
Increase (decrease) in shareholders' equity (deficit)
Issuance of ADSs upon exercise of share options		1			1
Issuance of ADSs upon exercise of share options (in shares)	877
Issuance of ADSs, net of commissions and offering expenses	$ 1	2,715			2,716
Issuance of ADSs, net of commissions and offering expenses (in shares)	100,000
Issuance of ADSs upon settlement of restricted share units	$ 1				1
Issuance of ADSs upon settlement of restricted share units (in shares)	56,988
Share-based compensation expense		9,042			9,042
Foreign currency translation adjustment			(316)		(316)
Net Income (Loss)				(39,064)	(39,064)
Ending balance at Mar. 31, 2023	$ 389	612,863	71	(370,160)	243,163
Ending balance (in shares) at Mar. 31, 2023	30,031,758
Beginning balance at Dec. 31, 2023	$ 550	883,446	(1,304)	(511,760)	$ 370,932
Beginning balance (in shares) at Dec. 31, 2023	42,431,766				42,431,766
Increase (decrease) in shareholders' equity (deficit)
Issuance of ADSs upon exercise of share options	$ 2	1,868			$ 1,870
Issuance of ADSs upon exercise of share options (in shares)	133,735
Issuance of ADSs upon settlement of restricted share units	$ 1				1
Issuance of ADSs upon settlement of restricted share units (in shares)	67,096
Share-based compensation expense		9,282			9,282
Foreign currency translation adjustment			526		526
Net Income (Loss)				(26,563)	(26,563)
Ending balance at Mar. 31, 2024	$ 553	$ 894,596	$ (778)	$ (538,323)	$ 356,048
Ending balance (in shares) at Mar. 31, 2024	42,632,597				42,632,597